Pharmabiz16h
Merck to present new data from Gardasil 9 studies reinforcing the importance of gender-neutral HPV vaccination in adults up to age 45 at IPVC 2024
Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...
China Internet Information Center2dOpinion
CIIE advances China's high-quality opening up
As the world's first national-level import-themed trade exhibition, the CIIE provides strong evidence of China's opening up ...
China Internet Information Center8d
Global firms capitalize on China's smart, green transformation
Aptiv is one of a number of multinationals gathering in Shanghai to test the pulse of China's smart manufacturing market, ...
sinchew13d
Merck Announces Emerging Biotech Grant Program Winners
Award recipients to receive in-kind technologies and services to accelerate therapeutics to market Merck experts to provide ...
Pharmabiz13d
Merck invests €70 million to expand ADC manufacturing for novel cancer therapies
Merck, a leading science and technology company, announced a €70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, ...
Zawya16d
Tanzania President, Merck Foundation Chairman and Chief Executive Officer (CEO) with 15 First Ladies inaugurate their 11th Africa Asia Luminary 2024
The 11th Edition of Merck Foundation Africa Asia Luminary was officially inaugurated by The President of the United Republic of Tanzania, H.E. Dr. SAMIA SULUHU HASSAN, Chairman of Merck Foundation ...
Ad Age17d
Merck—ad spending, facts and profile
Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...
AOL19d
Where Will Merck Be in 5 Years?
This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...
NDTV20d
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
Merck's recently approved vaccine, however, gives Pfizer some major competition. The shot, called Capvaxive, protects against bacterial strains that cause about 84% of cases of adult pneumoccocal ...
NDTV20d
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
The shots are also suggested for certain adults and children who are immunocompromised. A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by ...
Reuters27d
Germany's Merck open to more M&A for its Life Science division
Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...
Morningstar27d
Merck KGaA Shares Jump on Expectations of AI Boost — Update
Merck KGaA's shares jumped after the German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously expected over the medium term. The life ...